Literature DB >> 1320879

The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta.

M L Webb1, K E Dickinson, C L Delaney, E C Liu, R Serafino, R B Cohen, H Monshizadegan, S Moreland.   

Abstract

The purpose of this study was to examine the specificity of the cyclic pentapeptide ET(A) receptor antagonist BQ-123. BQ-123 competitively antagonized endothelin-1-induced contractions in rabbit aorta, increases in inositol phosphates in cultured rat vascular smooth muscle A10 cells, and binding of [125I]endothelin-1 to the cloned ETA receptor cDNA expressed in Cos 7 cells. In contrast, BQ-123 was a weak antagonist of [125I]endothelin-3 binding to rat cerebellar membranes and to membranes from Cos 7 cells transfected with the cloned ETB receptor cDNA. BQ-123 shifted concentration-response curves in isolated rabbit aorta elicited by angiotensin II, but did not bind to angiotensin II receptors nor affect angiotensin II-induced increases in inositol phosphates. BQ-123 also did not affect contractions induced by KCl or norepinephrine. These data suggest that endothelin may play a role in angiotensin II-induced contractions of rabbit aorta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320879     DOI: 10.1016/0006-291x(92)91710-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Cardiac fibroblasts produce leukemia inhibitory factor and endothelin, which combine to induce cardiac myocyte hypertrophy in vitro.

Authors:  K L King; J Lai; J Winer; E Luis; R Yen; J Hooley; P M Williams; J P Mather
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 4.  Role of endothelin in hypertension.

Authors:  B K Krämer; M Ackermann; S M Kohler; G A Riegger
Journal:  Clin Investig       Date:  1994-01

5.  Pre- and postjunctional actions of endothelin in the rat iris sphincter preparation.

Authors:  M Shinkai; H Tsuruoka; S Wakabayashi; Y Yamamoto; I Takayanagi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

Review 6.  New approaches for managing preeclampsia: clues from clinical and basic research.

Authors:  Eric M George
Journal:  Clin Ther       Date:  2014-11-20       Impact factor: 3.393

7.  Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.

Authors:  R R Wenzel; J Rüthemann; H Bruck; R F Schäfers; M C Michel; T Philipp
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

8.  Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries.

Authors:  R S Garcha; P S Sever; A D Hughes
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

9.  BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.

Authors:  K E Dickinson; R B Cohen; S Skwish; C L Delaney; R P Serafino; M A Poss; Z Gu; D E Ryono; S Moreland; J R Powell
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

10.  Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.

Authors:  E J Stevens; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.